In this podcast episode, Jean-Yves Blay, MD, PhD, and Robin L. Jones, BSc, MBBS, MRCP, MD(Res), discuss key data on using TKIs as monotherapy and in combination with chemotherapy or immune checkpoint inhibitors for treatment of soft tissue sarcoma and osteosarcoma.
In this podcast episode, Jean-Yves Blay, MD, PhD, and Robin L. Jones, BSc, MBBS, MRCP, MD(Res), discuss the most important clinical trial data on leveraging TKIs as monotherapy and in combination with chemotherapy or immune checkpoint inhibitors for treatment of soft tissue sarcoma and osteosarcoma.
Presenters:
Jean-Yves Blay, MD, PhD
Professor of Medical Oncology
Department of Medicine
Centre Leon Berard
Lyon, France
Robin L. Jones, BSc, MBBS, MRCP, MD(Res)
Professor
Sarcoma Unit
Royal Marsden Hospital and Institute of Cancer Research
London, United Kingdom
Link to full program, including accompanying downloadable slidesets:
https://bit.ly/2ZL9bxq